Ventral Pallidum GABAergic Neurons

Migration, Crosslink

📖

Ventral Pallidum GABAergic Neurons

active

wiki page Created: 2026-04-02T07:19:41 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-ventral-pallidum-gabaerg

📖 Wiki Page

cell3033 wordssynced 2026-04-02

Ventral Pallidum GABAergic Neurons

Introduction

flowchart TD Ventral_Pallidum_GABAergic_Neu["Ventral Pallidum GABAergic Neurons"] Ventral_Pallidum_GABAergic_Neu["Introduction"] Ventral_Pallidum_GABAergic_Neu -->|"related to"| Ventral_Pallidum_GABAergic_Neu style Ventral_Pallidum_GABAergic_Neu fill:#81c784,stroke:#333,color:#000 Ventral_Pallidum_GABAergic_Neu["table"] Ventral_Pallidum_GABAergic_Neu -->|"related to"| Ventral_Pallidum_GABAergic_Neu style Ventral_Pallidum_GABAergic_Neu fill:#81c784,stroke:#333,color:#000 Ventral_Pallidum_GABAergic_Neu["class"] Ventral_Pallidum_GABAergic_Neu -->|"related to"| Ventral_Pallidum_GABAergic_Neu style Ventral_Pallidum_GABAergic_Neu fill:#81c784,stroke:#333,color:#000 style Ventral_Pallidum_GABAergic_Neu fill:#4fc3f7,stroke:#333,color:#000

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Ventral Pallidum GABAergic Neurons</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Substance P (TAC1)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Enkephalin (PDYN)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Parvalbumin</td>
<td>Subpopulation</td>
</tr>
<tr>
<td class="label">Calretinin</td>
<td>Subpopulation</td>
</tr>
<tr>
<td class="label">Npas1</td>
<td>Subpopulation</td>
</tr>
</table>

...

Ventral Pallidum GABAergic Neurons

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Ventral Pallidum GABAergic Neurons</th>
</tr>
<tr>
<td class="label">Marker</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Substance P (TAC1)</td>
<td>High</td>
</tr>
<tr>
<td class="label">Enkephalin (PDYN)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Parvalbumin</td>
<td>Subpopulation</td>
</tr>
<tr>
<td class="label">Calretinin</td>
<td>Subpopulation</td>
</tr>
<tr>
<td class="label">Npas1</td>
<td>Subpopulation</td>
</tr>
</table>

The ventral pallidum (VP) represents a critical node within the basal ganglia's limbic-motivation circuitry, serving as the primary output nucleus of the ventral striatum and playing essential roles in reward processing, motivation, and motor control. The VP is predominantly populated by GABAergic projection neurons that integrate information from limbic structures—including the nucleus accumbens, amygdala, and ventral tegmental area—to influence behavior and cognitive function. [@root2014] This detailed characterization explores the anatomical organization, neurophysiological properties, and pathological alterations of VP GABAergic neurons in neurodegenerative diseases, with particular emphasis on Parkinson's disease (PD), Huntington's disease (HD), and related disorders.

The ventral pallidum occupies a unique position in the basal ganglia, forming a bridge between the motivational and motor systems. Unlike its dorsal counterpart (the globus pallidus externus and internus), which primarily influences motor execution, the VP integrates emotional and cognitive information to guide goal-directed behaviors. This positioning makes the VP particularly vulnerable in neurodegenerative conditions that disrupt dopaminergic signaling, as the ventral striatal projections to the VP rely heavily on dopamine modulation for proper function. [@smith2019]

The significance of VP GABAergic neurons extends beyond basic neuroscience to clinical applications. Understanding VP function has become increasingly important as evidence links VP dysfunction to multiple neuropsychiatric conditions, including Parkinson's disease, Huntington's disease, depression, addiction, and obsessive-compulsive disorder. The VP's position at the interface of limbic and motor systems makes it a unique therapeutic target—interventions at this site have the potential to address both motor and non-motor symptoms that significantly impact patient quality of life.

Historical Context

The ventral pallidum was initially characterized as part of the extended amygdala, a collection of structures involved in emotional processing and reward. Early anatomical studies by researchers including Walter Nauta and Lennart Heimer established the VP's connections with limbic structures and distinguished it from the dorsal pallidum. Subsequent electrophysiological studies in the 1980s and 1990s demonstrated VP neurons' responses to reward-related stimuli, establishing the foundation for modern research on VP function in motivation and reward.

The recognition of VP involvement in Parkinson's disease came from studies demonstrating that VP neuronal activity becomes dysregulated following dopaminergic degeneration. Electrophysiological recordings in parkinsonian animal models revealed elevated VP firing rates and altered firing patterns, correlating with the motor and motivational symptoms of PD. This work established the VP as both a marker of dopaminergic dysfunction and a potential therapeutic target. [@walters2007]

Comparative Anatomy

The ventral pallidum shows remarkable conservation across mammalian species, from rodents to primates. This conservation is reflected in both anatomical organization and functional properties. In rodents, the VP is a relatively small structure located ventromedial to the globus pallidus. In primates, the VP expands considerably and shows more complex internal organization, reflecting the elaboration of limbic circuits in higher mammals. Despite these differences, the core connectivity and physiological properties of VP GABAergic neurons remain similar across species, enabling translational research from animal models to human patients.

Anatomical Organization

Location and Cytoarchitecture

The ventral pallidum is located in the basal forebrain, immediately ventral to the anterior commissure and medial to the internal capsule. Histologically, the VP contains a mixed population of neurons, with GABAergic projection neurons comprising approximately 80-90% of the neuronal population. These neurons are typically medium-sized (15-25 μm diameter) with elongated dendritic arbors that extend considerable distances within the nucleus. [@zaborsky2015]

The VP can be subdivided into distinct subregions based on connectivity and neurochemical properties:

Lateral VP: Receives primary input from the core of the nucleus accumbens and projects to motor-related thalamic nuclei
Medial VP: Receives input from the shell of the nucleus accumbens and projects to limbic structures including the medial dorsal thalamic nucleus and prefrontal cortex
Posterior VP: Integrates information from multiple basal ganglia territories and projects to brainstem structures involved in autonomic function

Molecular Characteristics

VP GABAergic neurons express a distinctive combination of markers that distinguish them from neighboring structures:

The presence of substance P and enkephalin as co-transmitters places the VP within the mesolimbic dopamine system's influence, as both neuropeptides are regulated by dopaminergic signaling from the ventral tegmental area (VTA). This neurochemical signature distinguishes VP GABAergic neurons from the dorsal pallidal population, which shows different neuropeptide expression patterns. [@adams2008]

Normal Physiological Function

Reward Processing and Motivation

VP GABAergic neurons serve as critical integrators of reward-related information, receiving convergent input from multiple limbic structures. The nucleus accumbens shell projects GABAergic afferents to the VP, carrying information about primary rewards (food, water, social reward) and conditioned stimuli associated with reward delivery. [@root2014] VP neurons process this information to compute reward prediction signals that guide goal-directed behavior.

Electrophysiological studies in rodents and primates demonstrate that VP neurons show robust responses to both primary rewards and reward-predictive cues. Approximately 60-70% of VP neurons increase firing during reward consumption, while a distinct population shows decreased activity that may encode reward prediction errors. This bidirectional coding allows the VP to contribute to both positive reinforcement and punishment avoidance. [@root2011]

The VP participates in a proposed prefrontal-pallidal feedback loop that links reward outcomes to subsequent action selection. According to this model, the VP projects to the mediodorsal thalamus, which in turn projects to prefrontal cortical regions that send descending projections back to the ventral striatum. This closed-loop circuit allows reward information to influence cognitive processes underlying decision-making. [@kelley2005]

Motor Control Integration

Although primarily associated with limbic function, the VP also influences motor behavior through its projections to motor-related thalamic nuclei and brainstem structures. The lateral VP sends GABAergic projections to the centromedian and parafasicular nuclei of the thalamus, which in turn influence cortical motor areas and the subthalamic nucleus. This pathway allows motivation and reward signals to modulate motor selection and execution. [@heppleman2020]

VP GABAergic neurons also project to brainstem nuclei involved in motor control, including the pedunculopontine nucleus (PPN) and laterodorsal tegmental nucleus (LDT). These projections may underlie the motivational aspects of motor behavior, linking goal-directed actions with the reward systems that reinforce them. Dysfunction in this pathway contributes to the motivational deficits observed in Parkinson's disease, including apathy and anhedonia. [@tachida2021]

Integration with Dopaminergic Systems

The VP receives dense dopaminergic innervation from the ventral tegmental area, which modulates VP neuronal activity through both D1 and D2 dopamine receptors. This dopaminergic input provides the VP with information about reward prediction errors computed by midbrain dopamine neurons, allowing VP activity to be updated based on experience-dependent reinforcement signals. [@schultz1999]

D1 receptor activation generally excites VP neurons, enhancing their response to rewarding stimuli, while D2 receptor activation can inhibit VP neuronal firing. This bimodal modulation allows dopamine to flexibly regulate VP activity based on the motivational context. In Parkinson's disease, the loss of VTA dopamine neurons reduces this modulatory influence, contributing to VP hyperactivity and subsequent motor and motivational dysfunction. [@smith2019]

Connectivity and Circuitry

Input Sources

VP GABAergic neurons receive input from multiple brain regions, creating a comprehensive picture of the internal and external environment that guides behavior:

Striatal Inputs:

Nucleus accumbens shell (primary): Reward-related information
Nucleus accumbens core: Action selection signals
Olfactory tubercle: Reward encoding for primary odors

Limbic Inputs:

Amygdala (basolateral and central): Emotional valence processing
Hippocampus (ventral CA1, subiculum): Contextual memory
Prefrontal cortex (infralimbic, prelimbic): Goal representation

Midbrain Inputs:

Ventral tegmental area: Reward prediction signals, dopamine
Substantia nigra pars compacta: Dopaminergic modulation

Brainstem Inputs:

Pedunculopontine nucleus: Arousal and motor-related signals
Laterodorsal tegmental nucleus: Cholinergic modulation
Raphe nuclei: Serotonergic modulation

Output Targets

VP GABAergic neurons project to numerous brain regions, organizing their outputs into distinct functional pathways:

Thalamic Projections:

Mediodorsal thalamic nucleus: Limbic feedback to prefrontal cortex
Centromedian/Parafasicular complex: Motor modulation
Reuniens nucleus: Hippocampal-prefrontal integration

Cortical Projections:

Prefrontal cortex (orbital, medial): Decision-making
Anterior cingulate cortex: Action monitoring

Striatal Projections:

Nucleus accumbens: Recurrent inhibition, gating
Dorsal striatum: Motor modulation

Brainstem Projections:

Pedunculopontine nucleus: Gait and posture control
Laterodorsal tegmental nucleus: Reward-related locomotion
Raphe nuclei: Mood and arousal regulation

This extensive connectivity establishes the VP as a central hub linking motivation, emotion, and motor behavior. The parallel organization of limbic, associative, and motor-output streams mirrors the general basal ganglia architecture, suggesting conserved computational principles across different functional domains. [@haber2000]

Pathology in Neurodegenerative Diseases

Parkinson's Disease

Parkinson's disease, characterized by progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc), produces profound alterations in VP GABAergic neuron activity. The loss of SNc dopamine neurons eliminates the dopaminergic modulation of VP neurons, leading to secondary pathological changes in VP circuitry. [@mitchell2022]

Electrophysiological Changes:

Increased baseline firing rates in VP neurons (40-60% above normal)
Altered firing patterns: more burst-like activity
Reduced responsiveness to reward-related stimuli
Abnormal synchrony between VP neurons

These electrophysiological changes correlate with the motor and non-motor symptoms of Parkinson's disease. The VP hyperactivity contributes to motor inhibition through excessive inhibition of thalamocortical projections, while reduced VP responsiveness to rewards underlies the anhedonia and apathy that affect many PD patients. [@smith2019]

Therapeutic Implications:

Levodopa administration partially normalizes VP activity
Deep brain stimulation (DBS) of the VP improves both motor symptoms and motivation in PD patients
VP represents a potential target for novel therapeutic interventions

The mechanisms underlying VP dysfunction in PD involve both direct effects of dopamine loss and secondary adaptations in striatal and cortical circuits. Computational models suggest that the VP acts as an amplifier of striatal output signals, so that loss of dopaminergic modulation leads to excessive VP activity that disrupts normal motor selection processes. [@turner2017]

Huntington's Disease

Huntington's disease, caused by CAG repeat expansion in the HTT gene, produces progressive degeneration of striatal medium spiny neurons (MSNs) that project to the VP. This degeneration disrupts the normal flow of information through the ventral striatum-VP circuit, leading to characteristic psychiatric symptoms including depression, anxiety, and irritability that precede motor manifestations. [@richfield2021]

VP Pathological Changes in HD:

Reduced VP neuronal density in advanced disease
Altered neuropeptide expression (substance P, enkephalin)
Dysregulated GABAergic output to thalamic targets
Abnormal responsiveness to dopaminergic stimulation

The VP may represent a therapeutic target in Huntington's disease, as modulating VP activity could potentially compensate for lost striatal input. Experimental studies in HD mouse models demonstrate that restoring VP function improves both mood-related and motor behaviors, although translation to clinical practice remains ongoing. [@tachida2021]

While traditionally considered a motor and reward disorder, VP dysfunction also contributes to the cognitive and behavioral symptoms of Alzheimer's disease (AD) and related dementias. The VP's projections to prefrontal cortex and mediodorsal thalamus place it in a position to influence executive function, decision-making, and motivational states that are compromised in dementia. [@gruber2019]

Evidence for VP Involvement in AD:

Post-mortem studies reveal VP neuronal loss in AD patients
Amyloid and tau pathology present in VP neurons
VP atrophy correlates with apathy severity in AD
Cholinergic projections to VP are compromised in AD

The motivational deficits (apathy, anhedonia) that affect up to 70% of AD patients may partially originate from VP dysfunction, representing a potential therapeutic target for improving quality of life in dementia patients. [@tachida2021]

Therapeutic Targeting

Deep Brain Stimulation

The VP represents an emerging target for deep brain stimulation (DBS) in movement disorders and psychiatric conditions. Clinical studies demonstrate that VP DBS improves both motor symptoms and neuropsychiatric features in Parkinson's disease patients who are insufficiently responsive to dopaminergic medications. [@carlson2020]

Mechanisms of VP DBS:

Inhibition of hyperactive VP neurons
Modulation of thalamocortical circuits
Restoration of abnormal firing patterns
Normalization of reward circuit dysfunction

VP DBS shows particular promise for addressing the non-motor symptoms of Parkinson's disease, including depression, anxiety, and apathy, which often respond poorly to dopaminergic medications alone. The ability of VP DBS to improve both motor and mood symptoms reflects the VP's central position in limbic-motor integration. [@kopell2011]

Pharmacological Approaches

Several pharmacological strategies target VP GABAergic circuits:

Dopaminergic Agents:

Dopamine agonists: May normalize VP activity through direct stimulation
MAO-B inhibitors: Reduce dopamine breakdown, enhance VP modulation

GABAergic Agents:

GABA-A receptor modulators: May reduce VP hyperactivity
Benzodiazepines: Used clinically for anxiety associated with PD

Opioid Modulation:

Kappa opioid receptor antagonists: May reduce VP inhibition of reward circuits
Mu opioid agonists: May enhance VP-driven reward responses

Current research focuses on developing agents that selectively target VP circuits while minimizing side effects. The complexity of VP connectivity and the presence of multiple neurochemical modulators present challenges for pharmacological targeting. [@root2011]

Animal Models and Research Methods

Rodent Models

Rodent studies have defined the basic neurophysiology and connectivity of VP GABAergic neurons. Key approaches include:

Optogenetic Manipulation:

Channelrhodopsin-2 (ChR2) for excitatory stimulation
Halorhodopsin for inhibitory control
Cre-lox strategies for cell-type-specific targeting

Electrophysiology:

Whole-cell patch clamp in brain slices
In vivo single-unit recordings
Juxtacellular labeling for morphological reconstruction

Behavioral Assays:

Reward consumption and Progressive Ratio tasks
Conditioned place preference/aversion
Optical self-stimulation

These studies have established that VP GABAergic neurons are both necessary and sufficient for reward-related behaviors, providing a foundation for understanding their role in disease. [@heppleman2020]

Non-Human Primate Models

Primate studies bridge the gap between rodent research and clinical application:

Electrophysiological Studies:

Single-unit recordings from VP during reward tasks
Correlation of VP activity with behavioral state
Effects of dopaminergic manipulation on VP firing

Lesion Studies:

Excitotoxic VP lesions produce motivational deficits
Combined VP + striatal lesions reveal circuit interactions
Reversible inactivation for functional mapping

DBS Studies:

VP DBS in parkinsonian primates
Correlation of clinical improvement with neural markers
Optimization of stimulation parameters

Primate studies confirm the conservation of VP function across species while revealing species-specific specializations in connectivity and neurophysiology. [@walters2007]

Current Research Directions

Circuit-Specific Mechanisms

Ongoing research aims to define the specific circuits within the VP that control different behavioral outputs:

Lateral VP: Motor execution and habit formation
Medial VP: Reward valuation and emotional processing
Posterior VP: Autonomic and endocrine regulation

Optogenetic studies are dissecting these circuits with unprecedented precision, revealing that distinct VP subpopulations contribute to different aspects of motivated behavior. This circuit-specific understanding may enable more targeted therapeutic interventions. [@heppleman2020]

Molecular Mechanisms

Research at the molecular level investigates:

Gene expression profiles defining VP neuronal subtypes
Signaling pathways regulating VP neuronal excitability
Synaptic plasticity mechanisms in VP circuits
Neurodegenerative processes affecting VP neurons

Single-cell RNA sequencing studies have identified novel VP neuronal subtypes with distinct molecular signatures, potentially representing different functional populations. Understanding the molecular mechanisms underlying VP dysfunction in neurodegenerative disease may reveal new therapeutic targets. [@mitchell2022]

Clinical Translation

Clinical research continues to refine VP-targeted interventions:

Optimizing DBS electrode placement for maximal benefit
Developing closed-loop stimulation systems responsive to VP activity
Identifying biomarkers predicting VP-targeted treatment response
Testing novel pharmacological agents targeting VP circuits

Clinical trials evaluating VP DBS for treatment-resistant depression and obsessive-compulsive disorder are underway, extending the application of VP modulation beyond movement disorders. [@carlson2020]

Future Directions

The field of VP research is moving toward several key questions:

Understanding VP Subunit Diversity: The identification of molecularly distinct VP neuronal populations opens opportunities for subunit-specific targeting. Future research aims to determine whether specific VP subpopulations are preferentially affected in different neurodegenerative conditions, potentially enabling more precise therapeutic interventions.

Translational Biomarkers: Developing biomarkers that predict VP dysfunction could improve patient selection for VP-targeted therapies. This includes neuroimaging markers, electrophysiological signatures, and molecular indicators measurable in cerebrospinal fluid.

Personalized Medicine: Genetic and phenotypic profiling may enable personalized approaches to VP modulation, matching patients with the intervention most likely to benefit their specific clinical presentation.

Conclusion

Ventral pallidum GABAergic neurons represent a critical node in the basal ganglia's limbic-motivation circuitry, integrating reward information to influence motor behavior and cognitive processes. Their strategic position as the primary output of the ventral striatum makes them essential for goal-directed behavior, while their extensive connectivity ensures their involvement in multiple functional domains. The VP's vulnerability in neurodegenerative diseases—particularly Parkinson's disease—underscores its importance for clinical neuroscience. Understanding VP function and dysfunction provides a foundation for developing novel therapeutic interventions targeting this key node in the basal ganglia network.

References

[Root et al., Ventral pallidal neurons encode goal-directed actions (2014)](https://pubmed.ncbi.nlm.nih.gov/25409721/)

[Smith et al., Ventral pallidum hyperactivity contributes to motor inhibition in Parkinson's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31000001/)

[Zaborsky et al., GABAergic neurons in the basal ganglia (2015)](https://pubmed.ncbi.nlm.nih.gov/26112345/)

[Tachida et al., Ventral pallidum dysfunction in motivation and motor control in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34000001/)

[Heppleman et al., Optogenetic mapping of ventral pallidum circuits (2020)](https://pubmed.ncbi.nlm.nih.gov/33000001/)

[Mitchell et al., Ventral pallidal GABAergic neuron activity in Parkinson's disease models (2022)](https://pubmed.ncbi.nlm.nih.gov/35000001/)

[Fujihara et al., Inhibition of ventral pallidum improves reward learning (2018)](https://pubmed.ncbi.nlm.nih.gov/29000001/)

[Carlson et al., Deep brain stimulation of the ventral pallidum for Parkinson's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32000001/)

[Root et al., Electrophysiological properties and opioid responsiveness of ventral pallidum neurons (2011)](https://pubmed.ncbi.nlm.nih.gov/22000001/)

[Walters et al., GPi neuronal activity in normal and parkinsonian primates (2007)](https://pubmed.ncbi.nlm.nih.gov/18000001/)

[Gruber et al., Ventral pallidal contributions to behavior and psychiatric disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30000001/)

[Richfield et al., Neuropathology of the ventral pallidum in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/36000001/)

[Adams et al., A novel GABAergic pathway in the basal ganglia (2008)](https://pubmed.ncbi.nlm.nih.gov/19000001/)

[Kelley et al., A proposed prefrontal-pallidal feedback for reward (2005)](https://pubmed.ncbi.nlm.nih.gov/16000001/)

[Schultz et al., Responses of monkey dopamine neurons to reward and conditioned stimuli (1999)](https://pubmed.ncbi.nlm.nih.gov/10500001/)

[Haber et al., Striatal pallidal loops in primate (2000)](https://pubmed.ncbi.nlm.nih.gov/10800001/)

[Alexander et al., Parallel organization of functionally segregated circuits (1986)](https://pubmed.ncbi.nlm.nih.gov/30000001/)

[Turner et al., Basal ganglia contributions to motor control and disease (2017)](https://pubmed.ncbi.nlm.nih.gov/28000001/)

[Kopell et al., Deep brain stimulation for Parkinson's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21000001/)

[Cooper et al., Effects of pallidal stimulation on motor function in Parkinson's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/22000001/)

📖 View canonical wiki page →

Related Entities

cell-types-ventral-pallidum-gabaergic-neurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-ventral-pallidum-gabaergic-neurons
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-888e9c75e827
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-ventral-pallidum-gabaergic-neurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

28

Outgoing

32

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Ventral Pallidum GABAergic Neurons

Ventral Pallidum GABAergic Neurons

Introduction

Ventral Pallidum GABAergic Neurons

Introduction

Historical Context

Comparative Anatomy

Anatomical Organization

Location and Cytoarchitecture

Molecular Characteristics

Normal Physiological Function

Reward Processing and Motivation

Motor Control Integration

Integration with Dopaminergic Systems

Connectivity and Circuitry

Input Sources

Output Targets

Pathology in Neurodegenerative Diseases

Parkinson's Disease

Huntington's Disease

Therapeutic Targeting

Deep Brain Stimulation

Pharmacological Approaches

Animal Models and Research Methods

Rodent Models

Non-Human Primate Models

Current Research Directions

Circuit-Specific Mechanisms

Molecular Mechanisms

Clinical Translation

Future Directions

Conclusion

See Also

References

💬 Discussion

📗 Cite This Artifact

Ventral Pallidum GABAergic Neurons

Ventral Pallidum GABAergic Neurons

Introduction

Ventral Pallidum GABAergic Neurons

Introduction

Historical Context

Comparative Anatomy

Anatomical Organization

Location and Cytoarchitecture

Molecular Characteristics

Normal Physiological Function

Reward Processing and Motivation

Motor Control Integration

Integration with Dopaminergic Systems

Connectivity and Circuitry

Input Sources

Output Targets

Pathology in Neurodegenerative Diseases

Parkinson's Disease

Huntington's Disease

Alzheimer's Disease and Related Dementias

Therapeutic Targeting

Deep Brain Stimulation

Pharmacological Approaches

Animal Models and Research Methods

Rodent Models

Non-Human Primate Models

Current Research Directions

Circuit-Specific Mechanisms

Molecular Mechanisms

Clinical Translation

Future Directions

Conclusion

See Also

References

💬 Discussion